BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 28391621)

  • 1. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
    Ray JG; Ranganathan K; Chattopadhyay A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
    Phulari RGS; Dave EJ
    Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
    Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
    Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without.
    Chaturvedi P; Malik A; Nair D; Nair S; Mishra A; Garg A; Vaishampayan S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):225-230. PubMed ID: 28606826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management.
    Arakeri G; Brennan PA
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):587-93. PubMed ID: 23107623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
    Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
    Chattopadhyay A; Ray JG
    J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
    Auluck A; Rosin MP; Zhang L; Sumanth KN
    J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
    Mohiuddin S; Fatima N; Hosein S; Fatima N
    J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
    Coletta RD; Salo T
    Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral submucous fibrosis: review on mechanisms of malignant transformation.
    Ekanayaka RP; Tilakaratne WM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
    Bijai LK; Muthukrishnan A
    Oral Oncol; 2022 Apr; 127():105810. PubMed ID: 35303624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current protocols in the management of oral submucous fibrosis: An update.
    Arakeri G; Rai KK; Boraks G; Patil SG; Aljabab AS; Merkx MAW; Carrozzo M; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):418-423. PubMed ID: 28391602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.
    Xu H; Lyu FY; Song JY; Xu YM; Jiang EH; Shang ZJ; Chen LL; Xu Z
    Biomed Res Int; 2021; 2021():6631856. PubMed ID: 33791368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
    Fatima N; Mohiuddin S; Hosein S; Mervyn M
    J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Areca nut in pathogenesis of oral submucous fibrosis: revisited.
    Angadi PV; Rao SS
    Oral Maxillofac Surg; 2011 Mar; 15(1):1-9. PubMed ID: 20376683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral submucous fibrosis as a precancerous condition.
    Pindborg JJ; Murti PR; Bhonsle RB; Gupta PC; Daftary DK; Mehta FS
    Scand J Dent Res; 1984 Jun; 92(3):224-9. PubMed ID: 6589738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.